Stock Events

Stock Events

Cartesian Therapeutics (RNAC) Q1 2025 Earnings

13MarConfirmed

Q2 2024

Q3 2024

Q4 2024

Q1 2025

-10.5

-6.82

-3.14

0.54

Details

Expected EPS

-0.83

Actual EPS

-0.590508

Surprise EPS

0.24

Surprise Percent

+28.85%

Description

Cartesian Therapeutics (RNAC) has reported earnings of -0.590508 per share for Q1 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.